The FDA has expanded the clearance of an OTC glucose monitor to include children aged 2 years and older who do not use insulin.
The FDA expanded clearance of Dexcom's Stelo Glucose Biosensor System to individuals aged 2 years and older who do not use insulin.
Apple Watch blood sugar tracking remains unconfirmed. Here's the latest on the timeline, patents, technical challenges, and ...
The Food and Drug Administration (FDA) approved the first over-the-counter continuous glucose monitor for children under 18.
Compare Apple Watch CGM apps for blood sugar readings, including Dexcom G7, FreeStyle Libre, and Eversense watch support.
The U.S. Food and Drug Administration (FDA) has cleared the first over-the-counter wearable device to track blood sugar in ...
The U.S. Food and Drug Administration (FDA) on Friday cleared Dexcom Inc.‘s DXCM Stelo Glucose Biosensor System for ...
Dexcom has received Food and Drug Administration clearance for the first over-the-counter glucose sensor for children. The ...
The FDA’s indication expansion for Dexcom’s Stelo makes it the first over the counter CGM available for children, including those with diabetes.
Dexcom (Nadsaq:DXCM) has received FDA clearance for its Stelo over-the-counter (OTC) continuous glucose monitor (CGM) for ...
Dexcom warned that some lots of its G7 wearable glucose monitors were stolen on their way to the scrapyard and were sold by a third-party vendor. Two lots (1725204004 and 1725069002) of the company’s ...
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results